MicroRNA-433-3p promotes osteoblast differentiation through targeting DKK1 expression

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Dickkopf-1 (DKK1) is a crucial antagonist of the WNT signaling pathway and a biomarker for osteoporosis, correlating with bone mass and osteoblast maturation.
• Understanding the epigenetic regulation of DKK1 is vital for developing novel therapeutic strategies for osteoporosis.

Purpose of the Study:

• To investigate the epigenetic regulation of Dickkopf-1 (DKK1) translation by microRNA-433-3p (miR-433-3p).
• To elucidate the role of miR-433-3p in osteoblast differentiation and its potential as a therapeutic target for osteoporosis.

Main Methods:

• Luciferase reporter assays and Western blotting were used to validate the regulation of DKK1 by miR-433-3p.
• Lentivirus-mediated stable expression of miR-433-3p was employed in rat and human osteoblast cell lines.
• In situ hybridization and real-time PCR were used to detect miR-433-3p expression. An OVX rat model was established to mimic postmenopausal osteoporosis.

Main Results:

• miR-433-3p was found to directly regulate DKK1 mRNA translation, significantly inhibiting DKK1 protein expression by over 90%.
• Stable expression of miR-433-3p enhanced alkaline phosphatase (ALP) activity and mineral deposition in osteoblasts.
• Aberrant circulating levels of miR-433-3p were observed in an OVX rat model of osteoporosis, with a significant correlation between serum DKK1 and miR-433-3p.

Conclusions:

• miR-433-3p plays a critical role in the DKK1/WNT/β-catenin pathway by suppressing DKK1 expression, thereby promoting osteoblast differentiation.
• These findings highlight miR-433-3p as a potential therapeutic agent for osteoporosis by modulating DKK1 levels and enhancing bone formation.